Flexible Long-Term Capital
Our plc balance sheet enables us to take a longer-term view. We can provide companies with the flexible, long-term capital they require to grow.
Biotech Ventures for Public Markets
Arix provides public market investors with access to game changing life science innovation across a range of therapeutic areas and geographies.
We provide more than just capital when we invest. We take a board seat and play an active role to support our companies as they grow. We provide scientific and commercial experience to help navigate clinical and operational hurdles.
Partnerships with Takeda, UCB, Fosun and Ipsen provide access to extensive R&D insights and due diligence capabilities.
Extensive Global Networks
Premium access to innovation through our transatlantic team and high-quality global venture capital, biotech and academic networks.
Unconstrained by institution, geography or stage of company development; ability to source the best life science innovation without restriction.